Clinton Outlines Two New Cancer Initiatives

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 7 No 11
Volume 7
Issue 11

WASHINGTON--On the day of The March, President Clinton announced two new cancer initiatives and issued a challenge to cancer researchers that sounded more like a "Mission Impossible" assignment.

WASHINGTON--On the day of The March, President Clinton announced two new cancer initiatives and issued a challenge to cancer researchers that sounded more like a "Mission Impossible" assignment.

The President said that all federal cancer research programs will "by next year, fully integrate patients and advocates into the process of setting research priorities."

He also directed the National Cancer Institute to speed development of a national clinical trials program and to make it "a simple, accessible resource for health care providers and patients across our nation."

Mr. Clinton then challenged scientists "to develop, by the year 2000, new diagnostic techniques for every major kind of cancer so we catch it at its earliest and often most treatable stage."

Recent Videos
Taletrectinib showed improved efficacy in patients with ROS1-positive non–small cell lung cancer who were treatment-naïve.
“It’s a drug that I’m very comfortable with, and it is a drug I’ll likely use primarily in the first-line setting,” stated Jorge Nieva, MD, on taletrectinib in non–small cell lung cancer.
4 experts in this video
4 experts in this video
Those being treated for peritoneal carcinomatosis may not have to experience the complication rates or prolonged recovery associated with surgical options.
For patients with peritoneal carcinomatosis, integrating PIPAC into a treatment regimen does not interrupt their systemic therapy.